World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
10109
World Ranking
3641
National Ranking
1682

David E. Lanar publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David E. Lanar sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 128 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David E. Lanar D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David E. Lanar sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David E. Lanar is a researcher affiliated with the Walter Reed Army Institute of Research in the United States. Their work primarily focuses on topics related to infectious diseases, including malaria and HIV, with a strong emphasis on epidemiology and immunology.

The scientist has contributed to fields of study such as Medicine, Immunology and Microbiology, and Public Health, Environmental, and Occupational Health. Their subfields of specialization include Virology along with public health aspects related to disease control.

David E. Lanar's main research topics cover Malaria Research and Control, HIV Research and Treatment, and Mosquito-borne Diseases and Control. These areas reflect a focus on the study and management of pathogens that have a significant impact on global health.

Their recent publication record includes the following paper:

  • First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults, 2022, Vaccine

David E. Lanar frequently collaborates with several co-authors, including:

  • Jack Hutter
  • Paul M. Robben
  • Christine Lee
  • Melinda Hamer
  • James E. Moon

Their work has been featured in the journal Vaccine, marking the publication venue associated with their contributions.

Best Publications

  • Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

    Faith H. A. Osier;Faith H. A. Osier;Gregory Fegan;Gregory Fegan;Spencer D. Polley;Linda Murungi

  • A field trial to assess a blood-Stage malaria vaccine

    Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Matthew B. Laurens

  • Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax

    Ronald Rosenberg;Robert A. Wirtz;David E. Lanar;Jetsumon Sattabongkot

  • Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

    E J Pearce;S L James;S Hieny;D E Lanar

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

    J A Stoute;K E Kester;U Krzych;B T Wellde

  • Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria

    Spencer D. Polley;Tabitha Mwangi;Clemens H.M. Kocken;Alan W. Thomas

  • Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

    D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  • Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

    Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  • IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

    Samson M Kinyanjui;David J Conway;David E Lanar;Kevin Marsh

  • Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice.

    David E. Lanar;Edward J. Pearce;Stephanie L. James;Alan Sher

  • Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.

    Onome J. Akpogheneta;Onome J. Akpogheneta;Nancy O. Duah;Nancy O. Duah;Kevin K. A. Tetteh;Samuel Dunyo

  • Update on the clinical development of candidate malaria vaccines

    W. Ripley Ballou;Myriam Arevalo-Herrera;Daniel Carucci;Thomas L. Richie

  • NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

    J. A. Tine;D. E. Lanar;D. M. Smith;B. T. Wellde

  • A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria

    Stephen Abanega Kaba;Clara Brando;Qin Guo;Christian Mittelholzer

  • A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

    Alison Roth;Steven P. Maher;Steven P. Maher;Amy J. Conway;Ratawan Ubalee

  • Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

    Chandy C. John;Ann M. Moormann;Daniel C. Pregibon;Peter Odada Sumba

  • Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

    Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Dapa A. Diallo

  • Structural basis of antigenic escape of a malaria vaccine candidate

    Sheetij Dutta;Seung Yeon Lee;Adrian H. Batchelor;David E. Lanar

  • Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites

    Sheetij Dutta;J. David Haynes;J. Kathleen Moch;Arnoldo Barbosa

Frequent Co-Authors

D. Gray Heppner
D. Gray Heppner Crozet BioPharma
Kevin C. Kain
Kevin C. Kain University Health Network
Joe Cohen
Joe Cohen GlaxoSmithKline (United Kingdom)
W. Ripley Ballou
W. Ripley Ballou International AIDS Vaccine Initiative
Christian F. Ockenhouse
Christian F. Ockenhouse Walter Reed Army Institute of Research
Urszula Krzych
Urszula Krzych United States Army Research Laboratory
David L. Narum
David L. Narum National Institutes of Health
Kent E. Kester
Kent E. Kester Walter Reed Army Institute of Research
Christopher V. Plowe
Christopher V. Plowe University of Maryland, Baltimore
David J. Conway
David J. Conway London School of Hygiene & Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open multiple career pathways. Accelerated nursing programs can serve as a strong foundation, and the easiest ABSN programs to get into provide a fast track for students looking to advance quickly into clinical roles.

Another practical route in healthcare is becoming a licensed practical nurse (LPN). Many students prefer the fastest and easiest LPN programs, which allow entry into nursing care with relatively short program durations and flexible online options.

For those aiming higher in clinical practice, nurse practitioner degrees offer expanded responsibilities and autonomy. Identifying easy nurse practitioner programs to get into can help aspiring professionals embark on this career with less admission stress and comprehensive training.

Mental health focus within nursing is growing fast, and many students are drawn to psychiatric-mental health nurse practitioner (PMHNP) programs. The top online PMHNP programs are known for their excellent clinical placement rates, allowing students to gain vital hands-on experience while completing their degrees remotely.

Best Scientists Citing David E. Lanar

Trending Scientists

Recently Published Articles